Manufacturer record
Catasta Pharmaceuticals: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Catasta Pharmaceuticals (Himachal Pradesh) were declared Not of Standard Quality between September 2024 and August 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
4 records linked to Catasta Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Etoricoxib Tablets IP | CPT-250212Mfg 2025-05 · Exp 2027-01 | Assay for EtoricoxibAssay | KarnatakaState lab | Aug 2025 |
| Diclofenac Potassium & Paracetamol Tablets | CPT- 241506Mfg 2024-12 · Exp 2026-11 | Sample does not conforms to clain as per Patent & Proprietary in respect to the Assay of Diclofenac PottassiumAssay | DTL BADDIState lab | Mar 2025 |
| Deflazacort 6 mg Tablets | CPT- 241518Mfg 2024-12 · Exp 2026-11 | Sample does not conforms to clain as per Patent & Proprietary in respect to the Assay of Deflazacort.Assay | DTL BADDIState lab | Mar 2025 |
| Neurotem-NT | CPT-2698Mfg 2024-03 · Exp 2026-02 | The given Drug Sample does not comply to the contents of Assay with respect to Pregabalin ( 23.26% of claim)Assay | Drug Testing Laboratory Srinagar (J&K) vide report on Form 13 bearing No. L/DA/2024- 25/1191 Dated: 05.09.2024. (Report attached as Annexure A)State lab | Sep 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.